209.32
price up icon1.93%   3.97
pre-market  プレマーケット:  209.32  
loading
前日終値:
$205.35
開ける:
$207.04
24時間の取引高:
1.43M
Relative Volume:
1.33
時価総額:
$23.08B
収益:
$10.52B
当期純損益:
$999.00M
株価収益率:
25.03
EPS:
8.3628
ネットキャッシュフロー:
$1.22B
1週間 パフォーマンス:
+10.62%
1か月 パフォーマンス:
+20.00%
6か月 パフォーマンス:
+17.36%
1年 パフォーマンス:
+25.39%
1日の値動き範囲:
Value
$201.99
$210.38
1週間の範囲:
Value
$187.58
$210.38
52週間の値動き範囲:
Value
$157.20
$210.38

Quest Diagnostics Inc Stock (DGX) Company Profile

Name
名前
Quest Diagnostics Inc
Name
セクター
Healthcare (1108)
Name
電話
(973) 520-2700
Name
住所
500 PLAZA DRIVE, SECAUCUS
Name
職員
56,000
Name
Twitter
@QuestDX
Name
次回の収益日
2025-10-21
Name
最新のSEC提出書
Name
DGX's Discussions on Twitter

Compare DGX vs TMO, DHR, IDXX, A, WAT

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
DGX
Quest Diagnostics Inc
209.32 22.64B 10.52B 999.00M 1.22B 8.3628
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
527.17 202.81B 44.56B 6.73B 6.29B 17.74
Diagnostics & Research icon
DHR
Danaher Corp
219.98 155.34B 24.57B 3.60B 5.25B 5.0475
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
648.73 51.63B 4.30B 1.06B 1.04B 13.08
Diagnostics & Research icon
A
Agilent Technologies Inc
128.90 36.49B 6.95B 1.30B 1.15B 4.5696
Diagnostics & Research icon
WAT
Waters Corp
329.20 32.08B 3.11B 648.81M 602.27M 10.88

Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-01-30 アップグレード Barclays Equal Weight → Overweight
2025-08-25 ダウングレード Robert W. Baird Outperform → Neutral
2025-04-02 開始されました Redburn Atlantic Buy
2025-03-04 ダウングレード Citigroup Buy → Neutral
2025-01-06 アップグレード Leerink Partners Market Perform → Outperform
2024-12-17 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-12-10 再開されました Jefferies Buy
2024-10-23 アップグレード Robert W. Baird Neutral → Outperform
2024-08-28 再開されました Evercore ISI In-line
2024-07-10 アップグレード Citigroup Neutral → Buy
2024-02-26 開始されました Leerink Partners Market Perform
2024-02-07 アップグレード Jefferies Hold → Buy
2024-01-03 開始されました Barclays Equal Weight
2023-12-12 アップグレード BofA Securities Neutral → Buy
2023-06-29 開始されました Piper Sandler Neutral
2023-05-02 ダウングレード BofA Securities Buy → Neutral
2023-04-03 アップグレード Citigroup Sell → Neutral
2023-01-23 開始されました Evercore ISI In-line
2022-11-17 ダウングレード Citigroup Neutral → Sell
2022-08-22 再開されました Morgan Stanley Equal-Weight
2022-04-04 ダウングレード Citigroup Buy → Neutral
2022-02-23 ダウングレード UBS Buy → Neutral
2022-02-02 ダウングレード Jefferies Buy → Hold
2022-01-28 ダウングレード Deutsche Bank Buy → Hold
2021-05-04 アップグレード UBS Neutral → Buy
2021-03-12 ダウングレード Robert W. Baird Outperform → Neutral
2020-10-21 アップグレード Argus Hold → Buy
2020-07-29 アップグレード KeyBanc Capital Markets Sector Weight → Overweight
2020-07-14 アップグレード BofA Securities Neutral → Buy
2020-06-09 アップグレード Wells Fargo Underweight → Equal Weight
2020-06-02 アップグレード Deutsche Bank Hold → Buy
2020-04-28 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-04-27 アップグレード Citigroup Neutral → Buy
2020-04-27 アップグレード Wolfe Research Underperform → Peer Perform
2020-03-27 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-01-08 開始されました Wells Fargo Underweight
2020-01-07 ダウングレード Barclays Overweight → Equal Weight
2019-12-19 アップグレード BofA/Merrill Underperform → Neutral
2019-07-15 ダウングレード Goldman Neutral → Sell
2019-04-02 アップグレード Jefferies Hold → Buy
2019-03-18 再開されました Credit Suisse Neutral
2019-01-31 ダウングレード Argus Buy → Hold
2019-01-17 開始されました UBS Neutral
2019-01-03 ダウングレード BofA/Merrill Neutral → Underperform
2018-12-03 ダウングレード BofA/Merrill Buy → Neutral
2018-11-30 ダウングレード Goldman Buy → Neutral
すべてを表示

Quest Diagnostics Inc (DGX) 最新ニュース

pulisher
Feb 11, 2026

Forecasting The Future: 6 Analyst Projections For Quest Diagnostics - Benzinga

Feb 11, 2026
pulisher
Feb 11, 2026

Quest Diagnostics (DGX): Truist Securities Raises Price Target A - GuruFocus

Feb 11, 2026
pulisher
Feb 11, 2026

UBS Raises Price Target for Quest Diagnostics (DGX) to $210 | DG - GuruFocus

Feb 11, 2026
pulisher
Feb 11, 2026

Deutsche Bank Adjusts Quest Diagnostics Price Target to $205 From $178, Maintains Hold Rating - marketscreener.com

Feb 11, 2026
pulisher
Feb 11, 2026

DGX: Evercore ISI Group Raises Price Target for Quest Diagnostics | DGX Stock News - GuruFocus

Feb 11, 2026
pulisher
Feb 11, 2026

Quest Diagnostics (DGX): Navigating the New Frontier of Advanced Diagnostics and AI Efficiency - FinancialContent

Feb 11, 2026
pulisher
Feb 11, 2026

Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance

Feb 11, 2026
pulisher
Feb 11, 2026

Evercore ISI Adjusts Quest Diagnostics PT to $220 From $190, Maintains In Line Rating - marketscreener.com

Feb 11, 2026
pulisher
Feb 11, 2026

Quest Diagnostics Incorporated (NYSE:DGX) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 11, 2026
pulisher
Feb 11, 2026

DGX: Jefferies Raises Target Price for Quest Diagnostics to $220 - GuruFocus

Feb 11, 2026
pulisher
Feb 11, 2026

Truist Raises Price Target on Quest Diagnostics to $220 From $205, Keeps Hold Rating - marketscreener.com

Feb 11, 2026
pulisher
Feb 11, 2026

Candriam S.C.A. Has $13.69 Million Stake in Quest Diagnostics Incorporated $DGX - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Quest Diagnostics Shares Jump on Q4 Beat; FY25 Revenue Rises, 2026 Outlook Raised - AlphaStreet News

Feb 11, 2026
pulisher
Feb 10, 2026

Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MSN

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics Q4 Earnings Call Highlights - Yahoo Finance

Feb 10, 2026
pulisher
Feb 10, 2026

Jefferies Maintains Buy on Quest Diagnostics (DGX) Feb 10, 2026 - Meyka

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics: Q4 Earnings Snapshot - theheraldreview.com

Feb 10, 2026
pulisher
Feb 10, 2026

Why Is Quest (DGX) Stock Soaring Today - Finviz

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics Inc (DGX) Q4 2025 Earnings Call Highlights: St - GuruFocus

Feb 10, 2026
pulisher
Feb 10, 2026

Why Is Quest Diagnostics Stock Soaring Tuesday?Quest Diagnostics (NYSE:DGX) - Benzinga

Feb 10, 2026
pulisher
Feb 10, 2026

Quest's (NYSE:DGX) Q4 CY2025: Beats On Revenue - Finviz

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics (DGX) Earnings Call Transcript - The Globe and Mail

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics (DGX) Sees Significant Stock Price Surge - GuruFocus

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics Incorporated announces an Increase in Equity Buyback - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics Stock Gains 7% Over Increased Profit In Q4 - Nasdaq

Feb 10, 2026
pulisher
Feb 10, 2026

Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010. - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics hits 52-week high on outlook (DGX:NYSE) - Seeking Alpha

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics' Q4 Earnings & Revenues Beat Estimates, Stock Up - Yahoo Finance

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics (NYSE:DGX) Sets New 12-Month High Following Strong Earnings - MarketBeat

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics stock hits all-time high at $198.00 By Investing.com - Investing.com Canada

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics stock hits all-time high at $198.00 - Investing.com

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics Seeks Independent Lab Acquisitions - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics forecasts 2026 profit, revenue above estimates on lab test demand - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics Incorporated Provides Earnings Guidance for the Full Year 2026 - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics (DGX) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics (NYSE:DGX) Issues FY 2026 Earnings Guidance - MarketBeat

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics Q4 Adjusted Earnings, Revenue Rise; 2026 Guidance Set -- Shares Up Pre-Bell - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics Posts Strong 2025 Results, Boosts Shareholder Returns - TipRanks

Feb 10, 2026
pulisher
Feb 10, 2026

(DGX) Quest Diagnostics Expects 2026 Revenue Range $11.7B$11.82B, vs. FactSet Est of $11.38B - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

(DGX) Quest Diagnostics Expects 2026 Adjusted EPS Range $10.50$10.70, vs. FactSet Est of $10.44 - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics Raises Share Buyback Capacity by $1 Billion - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics Raises Quarterly Dividend by 7.5% to $0.86 a Share, Payable April 20 to Shareholders of Record as of April 6 - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

QUEST DIAGNOSTICS ($DGX) Releases Q4 2025 Earnings - Quiver Quantitative

Feb 10, 2026
pulisher
Feb 10, 2026

Quest’s (NYSE:DGX) Q4 CY2025: Beats On Revenue - TradingView

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics increases dividend 7.5% to $0.86 per quarter, marking 15 consecutive years of dividend increases; announces $1 billion increase in share repurchase authorization - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

Earnings Breakdown: Quest Diagnostics Q4 - Benzinga

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share - Yahoo Finance

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics Announces Dividend Increase and Share Repurchase Authorization - Intellectia AI

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics Increases Dividend 7.5% To $0.86 Per Quarter, Marking 15 Consecutive Years of Dividend Increases; Announces $1 Billion Increase in Share Repurchase Authorization - PR Newswire

Feb 10, 2026
pulisher
Feb 10, 2026

Quest Diagnostics Incorporated $DGX Shares Sold by Midwest Trust Co - MarketBeat

Feb 10, 2026
pulisher
Feb 09, 2026

Quest Diagnostics: Fourth Quarter Earnings Overview - Bitget

Feb 09, 2026

Quest Diagnostics Inc (DGX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
diagnostics_research LH
$289.89
price up icon 1.89%
diagnostics_research MTD
$1,392.65
price down icon 0.55%
$212.46
price up icon 0.38%
diagnostics_research IQV
$177.18
price down icon 2.89%
diagnostics_research WAT
$329.20
price up icon 0.67%
大文字化:     |  ボリューム (24 時間):